Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 365

3.

In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus and heterogeneous vancomycin-intermediate S. aureus in a hollow fiber model.

Vidaillac C, Leonard SN, Rybak MJ.

Antimicrob Agents Chemother. 2009 Nov;53(11):4712-7. doi: 10.1128/AAC.00636-09.

4.

Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.

Werth BJ, Sakoulas G, Rose WE, Pogliano J, Tewhey R, Rybak MJ.

Antimicrob Agents Chemother. 2013 Jan;57(1):66-73. doi: 10.1128/AAC.01586-12. Erratum in: Antimicrob Agents Chemother. 2013 Mar;57(3):1565.

7.

Pharmacodynamics of ceftaroline against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.

MacGowan AP, Noel AR, Tomaselli S, Bowker KE.

Antimicrob Agents Chemother. 2013 Jun;57(6):2451-6. doi: 10.1128/AAC.01386-12.

8.

In vitro pharmacodynamics of human simulated exposures of ceftaroline and daptomycin against MRSA, hVISA, and VISA with and without prior vancomycin exposure.

Bhalodi AA, Hagihara M, Nicolau DP, Kuti JL.

Antimicrob Agents Chemother. 2014;58(2):672-7. doi: 10.1128/AAC.01516-13.

9.
11.
13.
14.

Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin.

Mélard A, Garcia LG, Das D, Rozenberg R, Tulkens PM, Van Bambeke F, Lemaire S.

J Antimicrob Chemother. 2013 Mar;68(3):648-58. doi: 10.1093/jac/dks442.

15.
16.
17.
18.

In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program.

Biedenbach DJ, Alm RA, Lahiri SD, Reiszner E, Hoban DJ, Sahm DF, Bouchillon SK, Ambler JE.

Antimicrob Agents Chemother. 2015 Oct 26;60(1):343-7. doi: 10.1128/AAC.01867-15.

19.
20.
Items per page

Supplemental Content

Support Center